实用肝脏病杂志 ›› 2026, Vol. 29 ›› Issue (3): 438-441.doi: 10.3969/j.issn.1672-5069.2026.03.030

• 肝癌 • 上一篇    下一篇

超声造影联合血清AFP和PIVKA-II水平鉴别良恶性肝肿瘤应用价值研究*

谭春梅, 王庆庆, 刘洁, 范英   

  1. 646200 四川省泸州市 西南医科大学附属合江医院超声医学科(谭春梅);附属医院超声科(王庆庆,刘洁,范英)
  • 收稿日期:2024-11-04 出版日期:2026-05-10 发布日期:2026-05-18
  • 通讯作者: 范英,E-mail:2639828901@qq.com
  • 作者简介:谭春梅,女,41岁,大学本科,副主任医师。E-mail:dfm9817@163.com
  • 基金资助:
    *四川省科技厅科研计划项目(编号:2024NSFSC0725)

Contrast-enhanced ultrasound in combination with serum AFP, PIVKA-II and SP70 levels in the diagnosis of patients with intrahepatic space-occupying lesions

Tan Chunmei, Wang Qingqing, Liu Jie, et al   

  1. Department of Ultrasound, Hejiang Hospital Affiliated to Southwest Medical University, Luzhou 646200, Sichuan Province, China
  • Received:2024-11-04 Online:2026-05-10 Published:2026-05-18

摘要: 目的 探讨血清甲胎蛋白(AFP)、维生素K缺乏或拮抗剂-Ⅱ诱导蛋白(PIVKA-II)和肿瘤特异性蛋白70(SP70)水平联合超声造影(CEUS)参数判定肝占位性病变性质的效能。方法 2021年6月~2024年10月我院诊治的81例肝占位性病变患者,经组织病理学检查诊断,术前均接受CEUS检查,记录始增时间(OT)、始增强度(IEI)、达峰时间(TTP)、峰值加速时间(PAT)、峰值强度(PI)和120秒回声强度(EI-120s),采用ELISA法检测血清AFP、PIVKA-Ⅱ和SP70水平,应用多因素Logistic回归分析提示肝恶性肿瘤的危险因素,应用ROC分析诊断效能。结果 在 81 例肝占位性病变患者中,组织病理学检查诊断良性病变35 例和肝细胞癌(HCC)46 例;HCC病灶CEUS检查TIP为(48.4±5.6)s,显著短于良性病灶【(56.8±8.1)s,P<0.05】,而PI为(162.5±37.5)dB,显著大于良性病灶【(124.4±26.4)dB,P<0.05】;HCC组血清AFP、PIVKA-II和SP70水平分别为(782.9±189.2)ng/mL、(136.3±59.1)mAU/mL和(16.1±6.9)ng/mL,均显著高于良性组【分别为(7.9±1.8)ng/mL、(44.6±18.5)mAU/mL和(9.1±4.0)ng/mL,P<0.05】;经多因素Logistic分析显示,峰值强度、达峰时间及血清AFP、PIVKA-II和SP70水平均是提示肝恶性肿瘤的独立因素(P<0.05);ROC曲线分析显示,CEUS参数联合血清指标判定肝内占位性病变性质的AUC为0.980(95%CI:0.948~1.000),其灵敏度为93.5%,特异度为97.1%。结论 应用CEUS参数联合血清AFP、PIVKA-II和SP70水平判定肝内占位性病变性质的效能较高,可为临床提供较可靠的诊断依据。

关键词: 肝肿瘤, 超声造影, 肿瘤特异性蛋白70, 甲胎蛋白, 异常凝血酶原, 诊断

Abstract: Objective The aim of this study was to investigate the diagnostic efficacy of contrast-enhanced ultrasound (CEUS) in combination with serum alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-Ⅱ (PIVKA-II) and tumor-specific protein 70 (SP70) levels in patients with intrahepatic space-occupying lesions (SOL). Methods 81 patients with intrahepatic SOL were encountered in our hospital between June 2021 and October 2024, and the diagnosis was proven by histo-pathological examination. At presentation, all patients underwent CEUS to record onset time (OT), initial enhancement intensity (IEI), time to peak (TTP), peak acceleration time (PAT), peak intensity (PI) and echo intensity at 120 seconds (EI-120s). Serum AFP, PIVKA-II and SP70 levels were detected by ELISA. Multivariate Logistic regression analysis was performed to assess risk factors associated with malignant liver tumors, and ROC curve analysis was applied to evaluate diagnostic efficacy. Results Of the 81 patients with intrahepatic SOL, histo-pathological examination proved benign lesions in 35 cases and hepatocellular carcinoma (HCC) in 46 cases; the TIP from CEUS in patients with HCC was (48.4±5.6)s, much shorter than [(56.8±8.1)s, P<0.05], while the PI was (162.5±37.5)dB, much greater than [(124.4±26.4)dB, P<0.05] in those with benign lesions; serum AFP, PIVKA-II and SP70 levels in patients with HCC were (782.9±189.2)ng/mL,(136.3±59.1)mAU/mL and (16.1±6.9)ng/mL, all significantly higher than [(7.9±1.8)ng/mL, (44.6±18.5)mAU/mL and (9.1±4.0)ng/mL, respectively, P<0.05] in those with benign lesions; multivariate Logistic regression analysis showed that PT, TIP, serum AFP, PIVKA-II and SP70 levels were all the independent risk factors for malignant quality (P<0.05); ROC analysis demonstrated that the AUC was 0.980(95%CI:0.948-1.000), with sensitivity of 93.5% and specificity of 97.1%, when the CEUS parameters combined with serum markers in judging the quality of intrahepatic SOL. Conclusion The combination of serum AFP, PIVKA-II and SP70 levels with CEUS has a high diagnostic efficacy in patients with intrahepatic SOL, which might provide a relatively reliable diagnostic tool.

Key words: Hepatoma, Tumor-specific protein 70, Alpha-fetoprotein, Protein induced by vitamin K absence or antagonist-Ⅱ, Contrast-enhanced ultrasound, Diagnosis